The pathophysiology of the IDOs

The Australian Health & Medical Research Congress started today in Brisbane. We kick off proceedings by profiling renowned adult stem cell researcher, Elaine Fuchs.

US researchers find protein induces autophagy in ovarian cancer

Mitochondrial research discovers heart tissue regenerates in embryonic mice

Toby Sargeant has used new statistical techniques to trace the evolutionary development of the Plasmodium species of parasites and the relationship between different clades.

Alan Cowman’s group from WEHI may have found a weakness in the armour of the malaria parasite – by harnessing P. falciparum’s key defence strategy, they plan to turn it against itself.

Winning the 2008 NSW BioFirst Commercialisation award has come at exactly the right time for Special Phage Holdings, which has treated a patient in the clinic and is currently looking at a second round of private fundraising to develop its portfolio of bacteriophages

Unlisted Queensland biotech Xenome has reported good results in a Phase II trial of its candidate for chronic cancer pain relief and raised a good amount of cash to further its clinical development.

Western Australian company Orthocell is pioneering biological therapies to repair and regenerate damaged tendons and ligaments.

The Americans go to the polls in two months, and in the meantime many of the country’s regulatory agencies go into hibernation, including the all-important FDA.

A symposium at ComBio on wound healing promises to take audiences on a journey from basic cell biology right through to 3D skin scaffolds as therapies.